Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Computational Investigation of Homologous Recombination DNA Repair Deficiency in Sporadic Breast Cancer.

Wang Y, Ung MH, Cantor S, Cheng C.

Sci Rep. 2017 Nov 16;7(1):15742. doi: 10.1038/s41598-017-16138-2.

2.

Cancer cell line specific co-factors modulate the FOXM1 cistrome.

Wang Y, Ung MH, Xia T, Cheng W, Cheng C.

Oncotarget. 2017 Aug 24;8(44):76498-76515. doi: 10.18632/oncotarget.20405. eCollection 2017 Sep 29.

3.

The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients.

Mark KMK, Varn FS, Ung MH, Qian F, Cheng C.

BMC Cancer. 2017 May 2;17(1):306. doi: 10.1186/s12885-017-3297-2.

4.

MYC Mediates mRNA Cap Methylation of Canonical Wnt/β-Catenin Signaling Transcripts By Recruiting CDK7 and RNA Methyltransferase.

Posternak V, Ung MH, Cheng C, Cole MD.

Mol Cancer Res. 2017 Feb;15(2):213-224. doi: 10.1158/1541-7786.MCR-16-0247. Epub 2016 Nov 29.

5.

Application of RNAi-induced gene expression profiles for prognostic prediction in breast cancer.

Wang Y, Mark KM, Ung MH, Kettenbach A, Miller T, Xu W, Cheng W, Xia T, Cheng C.

Genome Med. 2016 Oct 27;8(1):114.

6.

In silico frameworks for systematic pre-clinical screening of potential anti-leukemia therapeutics.

Ung MH, Varn FS, Cheng C.

Expert Opin Drug Discov. 2016 Dec;11(12):1213-1222. Epub 2016 Oct 11. Review.

7.

Application of pharmacologically induced transcriptomic profiles to interrogate PI3K-Akt-mTOR pathway activity associated with cancer patient prognosis.

Ung MH, Wang GL, Varn FS, Cheng C.

Oncotarget. 2016 Dec 20;7(51):84142-84154. doi: 10.18632/oncotarget.11776.

8.

Integrative analysis of cancer genes in a functional interactome.

Ung MH, Liu CC, Cheng C.

Sci Rep. 2016 Jun 30;6:29228. doi: 10.1038/srep29228.

9.

Integrated Drug Expression Analysis for leukemia: an integrated in silico and in vivo approach to drug discovery.

Ung MH, Sun CH, Weng CW, Huang CC, Lin CC, Liu CC, Cheng C.

Pharmacogenomics J. 2017 Jul;17(4):351-359. doi: 10.1038/tpj.2016.18. Epub 2016 Mar 15.

10.

Integrative Genomic Analyses Yield Cell-Cycle Regulatory Programs with Prognostic Value.

Cheng C, Lou S, Andrews EH, Ung MH, Varn FS.

Mol Cancer Res. 2016 Apr;14(4):332-43. doi: 10.1158/1541-7786.MCR-15-0368. Epub 2016 Feb 8.

11.

IDEA: Integrated Drug Expression Analysis-Integration of Gene Expression and Clinical Data for the Identification of Therapeutic Candidates.

Ung MH, Varn FS, Cheng C.

CPT Pharmacometrics Syst Pharmacol. 2015 Jul;4(7):415-25. doi: 10.1002/psp4.51. Epub 2015 Jun 18.

12.

Regulators associated with clinical outcomes revealed by DNA methylation data in breast cancer.

Ung MH, Varn FS, Lou S, Cheng C.

PLoS Comput Biol. 2015 May 21;11(5):e1004269. doi: 10.1371/journal.pcbi.1004269. eCollection 2015 May.

13.

Integrative analysis of survival-associated gene sets in breast cancer.

Varn FS, Ung MH, Lou SK, Cheng C.

BMC Med Genomics. 2015 Mar 12;8:11. doi: 10.1186/s12920-015-0086-0.

14.

Protein mistranslation protects bacteria against oxidative stress.

Fan Y, Wu J, Ung MH, De Lay N, Cheng C, Ling J.

Nucleic Acids Res. 2015 Feb 18;43(3):1740-8. doi: 10.1093/nar/gku1404. Epub 2015 Jan 10.

Supplemental Content

Support Center